Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Errante

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Hodgkin's disease in 92 patients with HIV infection: the Italian experience. GICAT (Italian Cooperative Group on AIDS & Tumors)U Tirelli, D Errante, E Vaccher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1991
Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug users as the main group affected by HIV infectionU Tirelli, E Vaccher, A Lazzarin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Hodgkin's disease in patients with HIV infection and in the general population: comparison of clinicopathological features and survivalD Errante, V Zagonel, E Vaccher, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Incidence of seroconversion and progression of HIV disease among intravenous drug abusersE Vaccher, S Saracchini, D Errante, et al.
The Pharmacogenomics Journal|August 8, 2012
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimenE Cecchin, M D'Andrea, S Lonardi, et al.
Cancer|January 15, 1994
Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT)D Errante, U Tirelli, R Gastaldi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancerF Figoli, A Veronesi, M G Trovo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II studyG Nasti, D Errante, R Talamini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study GroupU Tirelli, D Errante, M Van Glabbeke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSFD Errante, J Gabarre, A L Ridolfo, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Hodgkin's disease in 92 patients with HIV infection: the Italian experience. GICAT (Italian Cooperative Group on AIDS & Tumors)U Tirelli, D Errante, E Vaccher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1991
Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug users as the main group affected by HIV infectionU Tirelli, E Vaccher, A Lazzarin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Hodgkin's disease in patients with HIV infection and in the general population: comparison of clinicopathological features and survivalD Errante, V Zagonel, E Vaccher, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Incidence of seroconversion and progression of HIV disease among intravenous drug abusersE Vaccher, S Saracchini, D Errante, et al.
The Pharmacogenomics Journal|August 8, 2012
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimenE Cecchin, M D'Andrea, S Lonardi, et al.
Cancer|January 15, 1994
Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT)D Errante, U Tirelli, R Gastaldi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancerF Figoli, A Veronesi, M G Trovo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II studyG Nasti, D Errante, R Talamini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study GroupU Tirelli, D Errante, M Van Glabbeke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSFD Errante, J Gabarre, A L Ridolfo, et al.
Pageof 7